67 related articles for article (PubMed ID: 32853950)
1. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
[TBL] [Abstract][Full Text] [Related]
2. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
3. Problems Associated with Deprescribing of Proton Pump Inhibitors.
Helgadottir H; Bjornsson ES
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
[TBL] [Abstract][Full Text] [Related]
4. The Morphologic Spectrum of Gastric Type 1 Enterochromaffin-Like Cell Neuroendocrine Tumors.
Poveda JC; Chahar S; Garcia-Buitrago MT; Montgomery EA; McDonald OG
Mod Pathol; 2023 Apr; 36(4):100098. PubMed ID: 36913909
[TBL] [Abstract][Full Text] [Related]
5. CHRONIC USE OF PROTON PUMP INHIBITORS AND THE QUANTITY OF G, D, AND ECL CELLS IN THE STOMACH.
Camilo SMP; Almeida ÉCS; Sousa JB; Camilo LP; Etchebehere RM
Arq Bras Cir Dig; 2020; 33(2):e1506. PubMed ID: 32844883
[TBL] [Abstract][Full Text] [Related]
6. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.
Melcescu E; Hogan RB; Brown K; Boyd SA; Abell TL; Koch CA
Exp Mol Pathol; 2012 Dec; 93(3):434-40. PubMed ID: 23043903
[TBL] [Abstract][Full Text] [Related]
7. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract][Full Text] [Related]
8. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.
Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A
J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Sex on the Response to Proton Pump Inhibitor Treatment.
Helgadottir H; Björnsson ES
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139847
[TBL] [Abstract][Full Text] [Related]
10. PPIs and gastric cancer: any causal relationship?
Crafa P; Franceschi M; Rodriguez-Castro KI; Franzoni L; Russo M; Brandimarte G; Tursi A; Rugge M; Di Mario F
Acta Biomed; 2023 Jun; 94(3):e2023096. PubMed ID: 37326271
[TBL] [Abstract][Full Text] [Related]
11. Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor.
Ikeda S; Takahashi T; Tandoh T; Ushiyama K; Kida Y
Intern Med; 2024; 63(5):649-657. PubMed ID: 38432892
[TBL] [Abstract][Full Text] [Related]
12. Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker.
Nagao S; Yabuuchi Y; Tanaka K; Morihisa Y; Kobayashi T; Akiyama S; Tanke G; Wada M; Morita S; Inoue S; Tei H; Yamashita D; Inokuma T
Intern Med; 2023 Nov; ():. PubMed ID: 38008447
[TBL] [Abstract][Full Text] [Related]
13. Ten-Fold Elevation of Chromogranin A Level Unrelated to a Neuroendocrine Tumor: A Case Report of the Diagnostic Interference of Proton Pump Inhibitors.
Alkhayat MJ; Davis K; Atkins SJ; Sheikh AA; Saif MW
Cureus; 2023 Oct; 15(10):e46862. PubMed ID: 37954718
[TBL] [Abstract][Full Text] [Related]
14. Association between occurrence of multiple white and flat elevated gastric lesions and oral proton pump inhibitor intake.
Hasegawa R; Yao K; Kanemitsu T; Arima H; Hirase T; Hiratsuka Y; Takeda K; Imamura K; Ohtsu K; Ono Y; Miyaoka M; Hisabe T; Ueki T; Tanabe H; Ohta A; Nimura S
Clin Endosc; 2024 Jan; 57(1):65-72. PubMed ID: 37157963
[TBL] [Abstract][Full Text] [Related]
15. Gastritis, Gastric Polyps and Gastric Cancer.
Waldum H; Fossmark R
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207192
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study.
Okanobu H; Kohno T; Mouri R; Hatsushika Y; Yamashita Y; Miyaki E; Fukuhara T; Okazaki A; Sakano A; Urabe A; Takaki S; Mori N; Tsuji K; Ochi H; Furukawa Y
Esophagus; 2021 Jul; 18(3):669-675. PubMed ID: 33221955
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials.
Fernández-González SM; Moreno-Álvarez A; Solar-Boga A
Children (Basel); 2024 Mar; 11(3):. PubMed ID: 38539331
[TBL] [Abstract][Full Text] [Related]
18. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
